Genomic Diversity of a Globally Used, Live Attenuated Mycoplasma Vaccine

Preventative measures, such as vaccination, are commonly used for the control of mycoplasmal infections in poultry. A live attenuated vaccine strain (Vaxsafe MS; MS-H; Bioproperties Pty. ABSTRACT The Mycoplasma synoviae live attenuated vaccine strain MS-H (Vaxsafe MS; Bioproperties Pty., Ltd., Australia) is commonly used around the world to prevent chronic infections caused by M. synoviae in birds and to minimize economic losses in the poultry industry. MS-H is a temperature-sensitive strain that is generated via the chemical mutagenesis of a virulent M. synoviae isolate, 86079/7NS. 32 single nucleotide polymorphisms have been found in the genome of MS-H compared to that of 86079/7NS, including 25 in predicted coding sequences (CDSs). There is limited information on the stability of these mutations in MS-H in vitro during the propagation of the vaccine manufacturing process or in vivo after the vaccination of chickens. Here, we performed a comparative analysis of MS-H genomes after in vitro and in vivo passages under different circumstances. Studying the dynamics of the MS-H population can provide insights into the factors that potentially affect the health of vaccinated birds. The genomes of 11 in vitro laboratory passages and 138 MS-H bird reisolates contained a total of 254 sequence variations. Of these, 39 variations associated with CDSs were detected in more than one genome (range = 2 to 62, median = 2.5), suggesting that these sequences are particularly prone to mutations. From the 25 CDSs containing previously characterized variations between MS-H and 86079/7NS, 7 were identified in the MS-H reisolates and progenies examined here. In conclusion, the MS-H genome contains individual regions that are prone to mutations that enable the restoration of the genotype or the phenotype of wild-type 86079/7NS in those regions. However, accumulated mutations in these regions are rare. IMPORTANCE Preventative measures, such as vaccination, are commonly used for the control of mycoplasmal infections in poultry. A live attenuated vaccine strain (Vaxsafe MS; MS-H; Bioproperties Pty. Ltd., Australia) is used for the prevention of disease caused by M. synoviae in many countries. However, information on the stability of previously characterized mutations in the MS-H genome is limited. In this study, we performed a comparative analysis of the whole-genome sequences of MS-H seeds used for vaccine manufacturing, commercial batches of the vaccine, cultures minimally passaged under small-scale laboratory and large-scale manufacturing conditions, MS-H reisolated from specific-pathogen-free (SPF) chickens that were vaccinated under controlled conditions, and MS-H reisolated from vaccinated commercial poultry flocks around the world. This study provides a comprehensive assessment of genome stability in MS-H after in vitro and in vivo passages under different circumstances and suggests that most of the mutations in the attenuated MS-H vaccine strain are stable.

[1]  M. Zubair,et al.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) moonlights as an adhesin in Mycoplasma hyorhinis adhesion to epithelial cells as well as a plasminogen receptor mediating extracellular matrix degradation , 2021, Veterinary Research.

[2]  S. Khurana,et al.  Insights on Mycoplasma gallisepticum and Mycoplasma synoviae infection in poultry: a systematic review , 2021, Animal biotechnology.

[3]  D. Tull,et al.  A Mycoplasma gallisepticum Glycerol ABC Transporter Involved in Pathogenicity , 2021, Applied and Environmental Microbiology.

[4]  A. Noormohammadi,et al.  Preliminary comparative analysis of the genomes of selected field reisolates of the Mycoplasma synoviae vaccine strain MS-H reveals both stable and unstable mutations after passage in vivo , 2020, BMC Genomics.

[5]  K. Bányai,et al.  Mutations potentially associated with decreased susceptibility to fluoroquinolones, macrolides and lincomycin in Mycoplasma synoviae. , 2020, Veterinary microbiology.

[6]  G. Browning,et al.  Comparative genomic analyses of Mycoplasma synoviae vaccine strain MS-H and its wild-type parent strain 86079/7NS: implications for the identification of virulence factors and applications in diagnosis of M. synoviae , 2019, Avian pathology : journal of the W.V.P.A.

[7]  C. Lartigue,et al.  Attenuation of a Pathogenic Mycoplasma Strain by Modification of the obg Gene by Using Synthetic Biology Approaches , 2019, mSphere.

[8]  A. Noormohammadi,et al.  Mutation of oppF gene in the Mycoplasma synoviae MS-H vaccine strain and its implication for differential serological responses to vaccination versus field challenge. , 2019, Veterinary microbiology.

[9]  R. Dumke,et al.  Organization of multi-binding to host proteins: The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Mycoplasma pneumoniae. , 2019, Microbiological research.

[10]  K. Bányai,et al.  Genotyping Mycoplasma synoviae: Development of a multi-locus variable number of tandem-repeats analysis and comparison with current molecular typing methods. , 2018, Veterinary microbiology.

[11]  Min Hu,et al.  Identification of erythrocyte membrane proteins interacting with Mycoplasma suis GAPDH and OSGEP. , 2018, Research in veterinary science.

[12]  N. Thomson,et al.  Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease , 2018, Vaccine.

[13]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[14]  Yi-ning Wang,et al.  Unique features of nucleotide and codon usage patterns in mycoplasmas revealed by information entropy , 2018, Biosyst..

[15]  M. McConville,et al.  Comparative Metabolomics of Mycoplasma bovis and Mycoplasma gallisepticum Reveals Fundamental Differences in Active Metabolic Pathways and Suggests Novel Gene Annotations , 2017, mSystems.

[16]  A. Kanci,et al.  Identification of a new genetic marker in Mycoplasma synoviae vaccine strain MS-H and development of a strategy using polymerase chain reaction and high-resolution melting curve analysis for differentiating MS-H from field strains. , 2017, Veterinary microbiology.

[17]  Tom L. Blundell,et al.  SDM: a server for predicting effects of mutations on protein stability , 2017, Nucleic Acids Res..

[18]  Melanie Pfeiffer,et al.  Network of Surface-Displayed Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with Human Plasminogen , 2015, Infection and Immunity.

[19]  Jian-hua Zhou,et al.  The Effect of Multiple Evolutionary Selections on Synonymous Codon Usage of Genes in the Mycoplasma bovis Genome , 2014, PloS one.

[20]  N. Verstraeten,et al.  Bacterial Obg proteins: GTPases at the nexus of protein and DNA synthesis , 2014, Critical reviews in microbiology.

[21]  P. Markham,et al.  High-Resolution Melting-Curve Analysis of obg Gene to Differentiate the Temperature-Sensitive Mycoplasma synoviae Vaccine Strain MS-H from Non-Temperature-Sensitive Strains , 2014, PloS one.

[22]  P. Markham,et al.  Mutations in GTP Binding Protein Obg of Mycoplasma synoviae Vaccine Strain MS-H: Implications in Temperature-Sensitivity Phenotype , 2013, PloS one.

[23]  S. Catania,et al.  Molecular Characterization of Acquired Enrofloxacin Resistance in Mycoplasma synoviae Field Isolates , 2013, Antimicrobial Agents and Chemotherapy.

[24]  P. Markham,et al.  Combination of differential growth at two different temperatures with a quantitative real-time polymerase chain reaction to determine temperature-sensitive phenotype of Mycoplasma synoviae , 2013, Avian pathology : journal of the W.V.P.A.

[25]  R. Dumke,et al.  Role of Mycoplasma pneumoniae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mediating interactions with the human extracellular matrix. , 2011, Microbiology.

[26]  P. Markham,et al.  GapA+ Mycoplasma gallisepticum ts-11 has improved vaccine characteristics. , 2011, Microbiology.

[27]  P. Markham,et al.  Developing attenuated vaccines to control mycoplasmoses , 2011 .

[28]  S. Djordjevic,et al.  Identification of Lipoprotein MslA as a Neoteric Virulence Factor of Mycoplasma gallisepticum , 2010, Infection and Immunity.

[29]  W. Landman,et al.  Induction of eggshell apex abnormalities by Mycoplasma synoviae: field and experimental studies , 2009, Avian pathology : journal of the W.V.P.A.

[30]  W. Haldenwang,et al.  The Growth-Promoting and Stress Response Activities of the Bacillus subtilis GTP Binding Protein Obg Are Separable by Mutation , 2008, Journal of bacteriology.

[31]  Sen-Lin Tang,et al.  Differential expression of lipoprotein genes in Mycoplasma pneumoniae after contact with human lung epithelial cells, and under oxidative and acidic stress , 2008, BMC Microbiology.

[32]  W. Landman,et al.  In vitro antibiotic susceptibility of Dutch Mycoplasma synoviae field isolates originating from joint lesions and the respiratory tract of commercial poultry , 2008, Avian pathology : journal of the W.V.P.A.

[33]  P. Dovc,et al.  Identification of major immunogenic proteins of Mycoplasma synoviae isolates. , 2008, Veterinary microbiology.

[34]  R. Gasser,et al.  Classification of Mycoplasma synoviae strains using single-strand conformation polymorphism and high-resolution melting-curve analysis of the vlhA gene single-copy region. , 2007, Microbiology.

[35]  K. Cecchini,et al.  Transcriptional Responses of Mycoplasma gallisepticum Strain R in Association with Eukaryotic Cells , 2007, Journal of bacteriology.

[36]  J. Meens,et al.  Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651. , 2006, Veterinary microbiology.

[37]  A. Noormohammadi,et al.  Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS. , 2006, Avian diseases.

[38]  V. Pereira,et al.  Avian mycoplasmosis update , 2005 .

[39]  R. Hoffmann,et al.  P80, the HinT interacting membrane protein, is a secreted antigen of Mycoplasma hominis , 2004, BMC Microbiology.

[40]  C. Gyles,et al.  Pathogenesis of bacterial infections in animals , 2004 .

[41]  V. Govorun,et al.  Mechanisms of Genetic Instability in Mollicutes (Mycoplasmas) , 2001, Russian Journal of Genetics.

[42]  B. Roe,et al.  Gene content and organization of an 85-kb DNA segment from the genome of the phytopathogenic mollicute Spiroplasma kunkelii , 2003, Molecular Genetics and Genomics.

[43]  J. Baseman,et al.  Surface localized glyceraldehyde‐3‐phosphate dehydrogenase of Mycoplasma genitalium binds mucin , 2003, Molecular microbiology.

[44]  C. Lima,et al.  Structural and biochemical analysis of the Obg GTP binding protein. , 2002, Structure.

[45]  I. Kempf,et al.  In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. , 2002, Veterinary microbiology.

[46]  S. Moriya,et al.  Deficiency of essential GTP‐binding protein ObgE in Escherichia coli inhibits chromosome partition , 2001, Molecular microbiology.

[47]  S. Uzzau,et al.  Sequence, cloning, expression and characterisation of the 81-kDa surface membrane protein (P80) of Mycoplasma agalactiae. , 2001, FEMS microbiology letters.

[48]  K. Wise,et al.  Coupled Phase-Variable Expression and Epitope Masking of Selective Surface Lipoproteins Increase Surface Phenotypic Diversity in Mycoplasma hominis , 2001, Infection and Immunity.

[49]  R. Karron,et al.  Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. , 2000, The Journal of infectious diseases.

[50]  J. Maddock,et al.  The N‐terminal domain of the Caulobacter crescentus CgtA protein does not function as a guanine nucleotide exchange factor , 2000, FEBS letters.

[51]  P. Markham,et al.  A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma synoviae , 2000, Molecular microbiology.

[52]  P. Scott,et al.  Field evaluation of the safety and efficacy of a temperature-sensitive Mycoplasma synoviae live vaccine. , 1998, Avian diseases.

[53]  C. Morrow,et al.  Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine. , 1998, Avian diseases.

[54]  C. Morrow,et al.  Production of temperature-sensitive clones of Mycoplasma synoviae for evaluation as live vaccines. , 1998, Avian diseases.

[55]  M. Stegemann,et al.  Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones , 1997, Antimicrobial agents and chemotherapy.

[56]  K. Wise,et al.  Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies , 1997, Infection and immunity.

[57]  K. Wise,et al.  Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation , 1996, Infection and immunity.

[58]  J. Hoch,et al.  Effects on Bacillus subtilis of a conditional lethal mutation in the essential GTP-binding protein Obg , 1994, Journal of bacteriology.

[59]  K. Whithear,et al.  Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. , 1990, Australian veterinary journal.

[60]  G. Barroso,et al.  Lethal and mutation frequency responses of Spiroplasma citri cells to UV irradiation. , 1989, Mutation research.

[61]  T E Carpenter,et al.  Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. , 1987, Avian diseases.

[62]  T. Farver,et al.  Immunization of chickens with temperature-sensitive mutants of Mycoplasma gallisepticum. , 1983, Avian diseases.

[63]  D. C. Krause,et al.  Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence , 1982, Infection and immunity.

[64]  B. Cox,et al.  Reversion analysis of [psi-] mutations in Saccharomyces cerevisiae. , 1981, Genetical research.

[65]  L. Babiuk,et al.  Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone , 1980, Infection and immunity.

[66]  D. P. Anderson,et al.  Field studies with Mycoplasma synoviae. , 1973, Avian diseases.

[67]  R. Hanson,et al.  A medium for the isolation of avian mycoplasmas. , 1968, American journal of veterinary research.

[68]  D. A. Munro,et al.  Studies of infectious synovitis in chickens. , 1956, American journal of veterinary research.